|
FTSJD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.116200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.828500E-04 |
| Normal-vs-Stage2 |
5.060800E-01 |
| Normal-vs-Stage3 |
8.008500E-02 |
| Normal-vs-Stage4 |
5.55179999999211E-05 |
| Stage1-vs-Stage2 |
2.533400E-01 |
| Stage1-vs-Stage3 |
7.902400E-01 |
| Stage1-vs-Stage4 |
8.044200E-02 |
| Stage2-vs-Stage3 |
3.875200E-01 |
| Stage2-vs-Stage4 |
5.496300E-02 |
| Stage3-vs-Stage4 |
2.149600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.295500E-03 |
| Normal-vs-AfricanAmerican |
1.396240E-03 |
| Normal-vs-Asian |
7.361200E-01 |
| Caucasian-vs-AfricanAmerican |
2.583200E-01 |
| Caucasian-vs-Asian |
5.216600E-01 |
| AfricanAmerican-vs-Asian |
4.442800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.342510E-03 |
| Normal-vs-Female |
7.455600E-02 |
| Male-vs-Female |
4.427800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.059500E-03 |
| Normal-vs-Extreme_Weight |
8.46870000000832E-05 |
| Normal-vs-Obese |
5.060200E-02 |
| Normal-vs-Extreme_Obese |
2.033400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.481000E-01 |
| Normal_Weight-vs-Obese |
2.075800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.400800E-01 |
| Extreme_Weight-vs-Obese |
6.589900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.491800E-01 |
| Obese-vs-Extreme_Obese |
7.834600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.416190E-02 |
| Normal-vs-Age(41-60Yrs) |
8.197700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.192500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.156200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.067600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.855400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.758050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.556000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.215790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.054500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.275400E-03 |
| Normal-VS-Type2 PRCC |
3.934200E-02 |
| Normal-VS-KIRP CIMP |
1.490010E-02 |
| Normal-VS-Unclassified PRCC |
4.754800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.730800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.601800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.157800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.516600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.273400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.102800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.034300E-02 |
| Normal-vs-N1 |
4.380700E-03 |
| Normal-vs-N2 |
1.46450000004794E-06 |
| N0-vs-N1 |
7.456200E-01 |
| N0-vs-N2 |
7.311600E-02 |
| N1-vs-N2 |
1.132490E-02 |
|
|
